Resources

Innovate UK funding for new precision cancer treatment technology

Sixfold Bioscience and Medicines Discovery Catapult (MDC) awarded Innovate UK grant to pursue ground-breaking project.

Target Identification with informatics and data mining

How informatics and data mining demonstrates which targets and target classes have the best chance of success

Ultrasound-triggered therapeutic microbubbles enhance the efficacy of cytotoxic drugs by increasing circulation and tumor drug accumulation and limiting bioavailability and toxicity in normal tissues

Target discovery at AstraZeneca: discovery, identification, and novel targets

The importance of selecting the right target

Translational Roadmap for the Organs-on-a-Chip Industry toward Broad Adoption

Investigating sex determination through MALDI MS analysis of peptides and proteins in natural fingermarks through comprehensive statistical modelling

Medicines Discovery Catapult expands Biosamples supply network to support UK innovators, creating one of the world’s largest virtual biobanks

Today, Medicines Discovery Catapult (MDC) announce the rapid expansion of its Biosamples supply network, creating one of the largest virtual biobanks worldwide accessible to life science innovators.

Nucleic Acid Therapeutics – Delivered

Nucleic acid therapeutics have been on the rise in recent years

Medicines Discovery Catapult awarded funding to establish Cheshire & Warrington as an international powerhouse for the creation of new medicines

Medicines Discovery Catapult announce that it has been awarded government seedcorn funding; provided through UK Research and Innovation’s flagship £236m Strength in Places Fund, along with project partner Cheshire & Warrington Local Enterprise Partnership (LEP).